A detailed history of Covestor LTD transactions in Arcellx, Inc. stock. As of the latest transaction made, Covestor LTD holds 1,616 shares of ACLX stock, worth $157,463. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,616
Previous 3 53766.67%
Holding current value
$157,463
Previous $0 Infinity%
% of portfolio
0.08%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$50.91 - $86.61 $82,117 - $139,701
1,613 Added 53766.67%
1,616 $135,000
Q3 2023

Nov 13, 2023

SELL
$31.51 - $37.4 $31 - $37
-1 Reduced 25.0%
3 $0
Q1 2023

May 15, 2023

BUY
$26.92 - $33.94 $107 - $135
4 New
4 $0

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $4.27B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.